296 related articles for article (PubMed ID: 10907387)
1. Methylphenidate: its pharmacology and uses.
Challman TD; Lipsky JJ
Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
Leonard BE; McCartan D; White J; King DJ
Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
[No Abstract] [Full Text] [Related]
3. Ritalin revisited: does it really help in neurological injury?
Kajs-Wyllie M
J Neurosci Nurs; 2002 Dec; 34(6):303-13. PubMed ID: 12506813
[TBL] [Abstract][Full Text] [Related]
4. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
5. Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
[No Abstract] [Full Text] [Related]
6. Methylphenidate: established and expanding roles in symptom management.
Prommer E
Am J Hosp Palliat Care; 2012 Sep; 29(6):483-90. PubMed ID: 22144657
[TBL] [Abstract][Full Text] [Related]
7. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Gerlach M; Grünblatt E; Lange KW
Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
[TBL] [Abstract][Full Text] [Related]
8. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
Hergüner S; Tanidir C
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
[No Abstract] [Full Text] [Related]
9. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
Cornell S
Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
[No Abstract] [Full Text] [Related]
10. [Neuropsychopharmacological effects of methylphenidate].
Ikeda K; Takamatsu Y; Hagino Y; Sora I
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
[TBL] [Abstract][Full Text] [Related]
11. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S;
J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2 Suppl):26S-49S. PubMed ID: 11833633
[TBL] [Abstract][Full Text] [Related]
12. Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Couzin J
Science; 2004 Aug; 305(5687):1088-9. PubMed ID: 15326317
[No Abstract] [Full Text] [Related]
13. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
Sasané R; Hodgkins P; Meijer W
Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
Prescrire Int; 2010 Feb; 19(105):5-8. PubMed ID: 20455329
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
17. Does methylphenidate influence cognitive performance?
Solanto MV
J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1323-5. PubMed ID: 9334541
[No Abstract] [Full Text] [Related]
18. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
19. [Methylphenidate. A possibility for rare hyperactive children].
Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
[No Abstract] [Full Text] [Related]
20. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Faraone SV
Neurosci Biobehav Rev; 2018 Apr; 87():255-270. PubMed ID: 29428394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
